Prognostic significance of neutrophil predominance in pleural fluid in patients with malignant effusion Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Elevated IL-18 levels in exudative pleural effusions, correlation with markers of pleural inflammation Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery Year: 2012
Characterization of the lymphocyte phenotype in bronchoalveolar lavage as a prognostic marker in pulmonary sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019
Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Analysis of T-cell subsets in patients with tuberculous pleural effusions Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Increased fraction of small round lymphocyte in BALF is a diagnostic indicator for sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
The implication of C-reactive protein in differentiation of various pleural effusion etiologies Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009
Diagnostic value of NT-proBNP levels in differentiation of cardiac origin of pleural effusions Source: Annual Congress 2008 - Pleural effusion Year: 2008
The significance of serum CA-125 and various tumour markers in pulmonary and pleural tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 156s Year: 2003
Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Significance of macrophage predominance in pleural effusions Source: Annual Congress 2003 - Pleural effusion Year: 2003